Chugai Pharma China

Chugai Pharma China is the primary operating entity in mainland China for Chugai Pharmaceutical, a leading Japanese biopharmaceutical company and a member of the Roche Group. Headquartered in Taizhou's China Medical City, the company integrates clinical development, manufacturing, and commercialization activities. It is particularly known for bringing innovative biologics and small molecules to the Chinese market in therapeutic areas such as oncology, hematology, and immunology. The company operates a state-of-the-art production facility in Taizhou that complies with international GMP standards. By leveraging Chugai's proprietary antibody engineering technologies, Chugai Pharma China aims to address significant unmet medical needs for patients across the region.